Skip to main content
Equibles
ANAB logo

ANAB · Anaptysbio, Inc

Track ANAB — free

Use ANAB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ANAB

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$56.28 -1.01 (-1.76%) At close · Aug 28
Russell 2000 member Rebalance outlook locked
Market Cap
$1.64B
Shares
29.10M

Anaptysbio, Inc Earnings Call Transcripts

Quarterly earnings calls for Anaptysbio, Inc (ANAB), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲41.6% $1.37M −$44.26M '23 Q1 23-05-11 ▲184.5% $3.46M −$39.84M '23 Q2 23-08-07 ▲156.6% $3.32M −$37.31M '23 Q3 23-11-02 ▲32.3% $9.01M −$42.21M '23 Q4 24-03-11 ▲286.8% $27.77M −$39.33M '25 Q1 25-05-05 ▲154.3% $76.32M $15.11M '25 Q3 25-11-04 LATEST ▼8% $25.56M −$52.88M '26 Q1 26-05-12
Earnings call
FY26 · Q1
2026-05-12
Anaptysbio, Inc (ANAB) Q1 2026 Earnings Call
Revenue
$25.56M
▼ 8% YoY
Diluted EPS
$-1.84
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-10
Anaptysbio, Inc (ANAB) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-04
Anaptysbio, Inc (ANAB) Q3 2025 Earnings Call
Revenue
$76.32M
▲ 154.3% YoY
Diluted EPS
$0.35
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2025-09-29
Anaptysbio, Inc (ANAB) September 2025 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q1
2025-05-05
Anaptysbio, Inc (ANAB) Q1 2025 Earnings Call
Revenue
$27.77M
▲ 286.8% YoY
Diluted EPS
$-1.28
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-11
Anaptysbio, Inc (ANAB) Q4 2023 Earnings Call
Revenue
$9.01M*
▲ 32.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Anaptysbio, Inc (ANAB) Q3 2023 Earnings Call
Revenue
$3.32M
▲ 156.6% YoY
Diluted EPS
$-0.94
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Anaptysbio, Inc (ANAB) Q2 2023 Earnings Call
Revenue
$3.46M
▲ 184.5% YoY
Diluted EPS
$-1.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Anaptysbio, Inc (ANAB) Q1 2023 Earnings Call
Revenue
$1.37M
▲ 41.6% YoY
Diluted EPS
$-1.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–9 of 9 earnings calls
Key facts CIK 1370053 CUSIP 032724106 13F (30d) 189 filings 188 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)